Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib in Advanced Biliary Tract Cancer With DNA Repair Gene Mutations
NCT04042831Phase 2Active, not recruiting
- Sponsor
- Academic and Community Cancer Research United
- Start
- Jun 2020
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in biliary tract cancer (BTC), sponsored by Academic and Community Cancer Research United. Started Jun 2020; status: active, not recruiting.
02
Drugs
olaparib
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04042831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042831.